Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Edwards Lifesciences Corporation EW

Healthcare  —  Medical Devices
86.29 0.56 0.65% as of 25 Sep
Market cap
$49.4B
P/E
49.6×
S&P 500 Member Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Edwards Lifesciences Corporation (EW) Price to free cash flow

As of 25 September 2026, Edwards Lifesciences Corporation (EW) trades at a price to free cash flow of 35.4×. Over the past ten years it has ranged from 14.3× (January 2015) to 226× (April 2024); the current reading is higher than 8% of that period. That is above the Medical Devices industry median of 22.5× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 38.2× (77.56%)
FY2024 170× 133.75%
FY2023 72.8× 50.36%
FY2022 48.4× (15.90%)
FY2021 57.6× (35.12%)
FY2020 88.8× 65.28%
FY2019 53.7× 14.82%
FY2018 46.8× 62.79%
FY2017 28.7× (31.75%)
FY2016 42.1× 6.69%

Quarterly

Period Price to free cash flow Change
Jun 2026 37.1× (15.14%)
Mar 2026 43.8× 14.59%
Dec 2025 38.2× (34.96%)
Sep 2025 58.7× (28.62%)
42 more quarters

Against its own ten years

Low 14.3× High 226×
Ten-year median 51.6×
Current reading's percentile 8

Price to free cash flow against peers

Company Price to free cash flow
PHG Koninklijke Philips N.V. compare 12.9×
ZBH Zimmer Biomet Holdings, Inc. compare 16.9×
BSX Boston Scientific Corporation compare 17.8×
MDT Medtronic PLC compare 18.5×
GEHC GE HealthCare Technologies Inc. compare 19.1×
STE STERIS plc compare 21.8×
SYK Stryker Corporation compare 22.2×
DXCM DexCom, Inc. compare 23.6×
EW Edwards Lifesciences Corporation 35.4×
Medical Devices industry median 22.5×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on EW